Page 416 - 第九版神经病学

406 第十七章周围神经疾病

[2] 中华医学会神经病学分会神经肌肉病学组，中华医学会神经病学分会肌电图及临床神经电生理学组，中华
医学会神经病学分会神经免疫学组 ． 中国慢性炎性脱髓鞘性多发性神经根神经病诊疗指南中华神经科杂
志， 2010 ,43 :586-588.

[3] 中华医学会神经病学分会神经肌肉病学组，中华医学会神经病学分会肌电图及临床神经电生理学组，中国
特发性面神经麻痹诊治指南中华神经科杂志， 2016 ,49 :84-86.

[ 4] Caporale CM, Capasso M. Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysac-
charide from a patient with Guillain-Barre syndrome. J Neuroimmunol,2006,174:12-20.

[ 5] Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm,

2008, 115 :585-591.
[ 6] Lewis RA. Chronic Inflammatory demyelinating polyneuropathy. Neurologic Clinics ,2007 ,25: 71-87.
[ 7] Obermann M, Yoon MS, Sensen K , et al. Efficacy of pregabalin in the treatment of trigeminal neural织a. Cephalal严

2008 ,28: 174-181.

[ 8 J Yuki N, Hartung HP. Guillain-Barre syndrome. N Engl J Med ,2012 ,366 :2294-2304.

[9] Hughes RA,Swan AV,van Doom PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database
Syst Rev,2010,16(6) :CD002063.

[ 10] Verboon C, van Doom PA ,Jacobs BC. Treatment dilemmas in Guillain-Barre syndrome. J Neurol Neurosurg Psychi-
atry,2017 ,88(4 ) :346-352.